1. Home
  2. MCW vs NNNN Comparison

MCW vs NNNN Comparison

Compare MCW & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mister Car Wash Inc.

MCW

Mister Car Wash Inc.

HOLD

Current Price

$5.75

Market Cap

1.5B

Sector

N/A

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$31.10

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCW
NNNN
Founded
1996
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
MCW
NNNN
Price
$5.75
$31.10
Analyst Decision
Buy
Analyst Count
11
0
Target Price
$7.68
N/A
AVG Volume (30 Days)
1.3M
30.0K
Earning Date
10-29-2025
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
22.84
N/A
EPS
0.27
0.06
Revenue
$1,041,660,000.00
$8,185,146.00
Revenue This Year
$6.86
N/A
Revenue Next Year
$6.87
N/A
P/E Ratio
$21.23
$598.39
Revenue Growth
6.98
21.95
52 Week Low
$4.61
$5.18
52 Week High
$8.60
$55.65

Technical Indicators

Market Signals
Indicator
MCW
NNNN
Relative Strength Index (RSI) 66.32 53.55
Support Level $5.59 $26.06
Resistance Level $5.82 $36.12
Average True Range (ATR) 0.15 6.11
MACD 0.05 -0.28
Stochastic Oscillator 90.12 29.57

Price Performance

Historical Comparison
MCW
NNNN

About MCW Mister Car Wash Inc.

Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: